Osaic Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$718K Sell
75,469
-7,297
-9% -$56.7K ﹤0.01% 3009
2025
Q4
$646K Buy
82,766
+21,011
+34% +$152K ﹤0.01% 3100
2025
Q3
$470K Buy
61,755
+13,144
+27% +$109K ﹤0.01% 3478
2025
Q2
$436K Buy
48,611
+4,466
+10% +$41.6K ﹤0.01% 3259
2025
Q1
$331K Buy
44,145
+15,976
+57% +$129K ﹤0.01% 3219
2024
Q4
$212K Buy
28,169
+14,953
+113% +$114K ﹤0.01% 3544
2024
Q3
$100K Buy
13,216
+7,699
+140% +$58.5K ﹤0.01% 4218
2024
Q2
$34.1K Sell
5,517
-745,177
-99% -$4.11M ﹤0.01% 4976
2024
Q1
$3.81M Buy
750,694
+57,665
+8% +$324K 0.01% 1226
2023
Q4
$4.15M Buy
693,029
+43,711
+7% +$253K 0.01% 1330
2023
Q3
$4.6M Buy
649,318
+46,229
+8% +$332K 0.01% 1363
2023
Q2
$4.25M Buy
603,089
+41,028
+7% +$329K 0.01% 1299
2023
Q1
$4.69M Sell
562,061
-5,857
-1% -$56.4K 0.01% 1202
2022
Q4
$6.52M Sell
567,918
-5,659
-1% -$70.6K 0.01% 943
2022
Q3
$7.23M Sell
573,577
-13,230
-2% -$170K 0.02% 811
2022
Q2
$6.21M Buy
586,807
+12,558
+2% +$130K 0.01% 912
2022
Q1
$9.34M Buy
574,249
+13,750
+2% +$221K 0.02% 793
2021
Q4
$7.76M Buy
560,499
+51,030
+10% +$675K 0.01% 868
2021
Q3
$7.32M Buy
509,469
+93,624
+23% +$1.48M 0.02% 824
2021
Q2
$6.58M Buy
415,845
+27,148
+7% +$369K 0.01% 885
2021
Q1
$3.95M Buy
388,697
+73,863
+23% +$762K 0.01% 1100
2020
Q4
$2.35M Buy
314,834
+150,241
+91% +$775K 0.01% 1320
2020
Q3
$565K Buy
164,593
+65,746
+67% +$282K ﹤0.01% 2322
2020
Q2
$471K Buy
98,847
+73,124
+284% +$292K ﹤0.01% 2394
2020
Q1
$51K Buy
+25,723
New +$70.8K ﹤0.01% 3952

Other funds holding BCRX